
Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
Ajjai Alva, Susan Slovin, Stephanie Daignault, Michael Carducci, Robert DiPaola, Ken Pienta, David Agus, Kathleen Cooney, Alice Chen, David C. Smith, Maha HussainVolume:
30
Langue:
english
Pages:
9
DOI:
10.1007/s10637-010-9573-5
Date:
April, 2012
Fichier:
PDF, 237 KB
english, 2012